SECAUCUS, N.J., Sept. 8,
2023 /PRNewswire/ -- Quest Diagnostics Incorporated
(NYSE: DGX), the world's leading provider of diagnostic information
services, announced that Sam Samad,
Executive Vice President and Chief Financial Officer, will speak on
the company's strategy, performance and the latest market
developments and trends during a fireside chat at the Baird 2023
Global Healthcare Conference in New York
City on Wednesday, September 13,
2023, at 2:00 p.m. Eastern
Time.
The presentation and Q&A session will be webcast live during
the conference and will be available on the company's investor
relations page which can be accessed at ir.QuestDiagnostics.com. In
addition, the archived webcast will be available within 24 hours
after the conclusion of the live event and will remain available
until October 13, 2023.
About Quest Diagnostics
Quest Diagnostics empowers
people to take action to improve health outcomes. Derived from the
world's largest database of clinical lab results, our diagnostic
insights reveal new avenues to identify and treat disease, inspire
healthy behaviors and improve health care management. Quest
annually serves one in three adult Americans and half the
physicians and hospitals in the United
States, and our nearly 50,000 employees understand that, in
the right hands and with the right context, our diagnostic insights
can inspire actions that transform lives.
www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-baird-2023-global-healthcare-conference-301922160.html
SOURCE Quest Diagnostics